AOA Dx
PrivateLast Round
Series A
Oct 12, 2023
Total Funding Raised
$46.8M
Company Overview
AOA Dx is a biotechnology company that develops an AI-enabled multi-omics liquid biopsy platform for the early detection of ovarian cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AOA Dx Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
AOA Dx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 12, 2023 | ||||
| Series A | Jul 1, 2023 | ||||
| Seed | Sep 13, 2022 | ||||
| Seed | Mar 1, 2022 | ||||
| Grant | Aug 16, 2021 | ||||
Pre Seed | Jun 28, 2021 |
Key People
Founding team and executive leadership
AOA Dx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Pre Seed |
| Canadian Institutes of Health Research | Grant |
| TBD Angels | Pre Seed |
| Gore Range Capital | Series A |
| Pioneer Fund | Pre Seed |
| Good Growth Capital | Series A |
| AlleyCorp | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Developing AKRIVIS GD™, an early-stage diagnostic for ovarian cancer.
- Oct 1, 2025
Introduced GlycoLocate™ for early cancer detection.
AOA Dx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AOA Dx's valuation, stock price, and market status.